195 related articles for article (PubMed ID: 22242170)
1. Impedance responses reveal β₂-adrenergic receptor signaling pluridimensionality and allow classification of ligands with distinct signaling profiles.
Stallaert W; Dorn JF; van der Westhuizen E; Audet M; Bouvier M
PLoS One; 2012; 7(1):e29420. PubMed ID: 22242170
[TBL] [Abstract][Full Text] [Related]
2. β
Galaz-Montoya M; Wright SJ; Rodriguez GJ; Lichtarge O; Wensel TG
J Biol Chem; 2017 Jun; 292(24):9967-9974. PubMed ID: 28442571
[TBL] [Abstract][Full Text] [Related]
3. Quantification of ligand bias for clinically relevant β2-adrenergic receptor ligands: implications for drug taxonomy.
van der Westhuizen ET; Breton B; Christopoulos A; Bouvier M
Mol Pharmacol; 2014 Mar; 85(3):492-509. PubMed ID: 24366668
[TBL] [Abstract][Full Text] [Related]
4. Adenylyl cyclase 2 selectively couples to E prostanoid type 2 receptors, whereas adenylyl cyclase 3 is not receptor-regulated in airway smooth muscle.
Bogard AS; Adris P; Ostrom RS
J Pharmacol Exp Ther; 2012 Aug; 342(2):586-95. PubMed ID: 22619251
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent G(s) signaling during beta2-adrenergic stimulation.
Jo SH; Leblais V; Wang PH; Crow MT; Xiao RP
Circ Res; 2002 Jul; 91(1):46-53. PubMed ID: 12114321
[TBL] [Abstract][Full Text] [Related]
6. RGS2 is a primary terminator of β₂-adrenergic receptor-mediated G(i) signaling.
Chakir K; Zhu W; Tsang S; Woo AY; Yang D; Wang X; Zeng X; Rhee MH; Mende U; Koitabashi N; Takimoto E; Blumer KJ; Lakatta EG; Kass DA; Xiao RP
J Mol Cell Cardiol; 2011 Jun; 50(6):1000-7. PubMed ID: 21291891
[TBL] [Abstract][Full Text] [Related]
7. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation.
Jordan BA; Trapaidze N; Gomes I; Nivarthi R; Devi LA
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):343-8. PubMed ID: 11134510
[TBL] [Abstract][Full Text] [Related]
8. Gbetagamma-mediated prostacyclin production and cAMP-dependent protein kinase activation by endothelin-1 promotes vascular smooth muscle cell hypertrophy through inhibition of glycogen synthase kinase-3.
Taurin S; Hogarth K; Sandbo N; Yau DM; Dulin NO
J Biol Chem; 2007 Jul; 282(27):19518-25. PubMed ID: 17513863
[TBL] [Abstract][Full Text] [Related]
9. Palmitoylation regulates intracellular trafficking of β2 adrenergic receptor/arrestin/phosphodiesterase 4D complexes in cardiomyocytes.
Liu R; Wang D; Shi Q; Fu Q; Hizon S; Xiang YK
PLoS One; 2012; 7(8):e42658. PubMed ID: 22912718
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical attenuation of β2-AR function in airway smooth muscle by Gi-mediated counterregulation in transgenic mice overexpressing type 5 adenylyl cyclase.
Wang WC; Schillinger RM; Malone MM; Liggett SB
Am J Physiol Lung Cell Mol Physiol; 2011 Mar; 300(3):L472-8. PubMed ID: 21131397
[TBL] [Abstract][Full Text] [Related]
11. β-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway.
Vidal M; Wieland T; Lohse MJ; Lorenz K
Cardiovasc Res; 2012 Nov; 96(2):255-64. PubMed ID: 22843704
[TBL] [Abstract][Full Text] [Related]
12. Membrane-permeable tastants amplify β2-adrenergic receptor signaling and delay receptor desensitization via intracellular inhibition of GRK2's kinase activity.
Malach E; Shaul ME; Peri I; Huang L; Spielman AI; Seger R; Naim M
Biochim Biophys Acta; 2015 Jul; 1850(7):1375-88. PubMed ID: 25857770
[TBL] [Abstract][Full Text] [Related]
13. Gq-mediated Ca2+ signals inhibit adenylyl cyclases 5/6 in vascular smooth muscle cells.
von Hayn K; Werthmann RC; Nikolaev VO; Hommers LG; Lohse MJ; Bünemann M
Am J Physiol Cell Physiol; 2010 Feb; 298(2):C324-32. PubMed ID: 19889965
[TBL] [Abstract][Full Text] [Related]
14. Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy.
Galandrin S; Bouvier M
Mol Pharmacol; 2006 Nov; 70(5):1575-84. PubMed ID: 16901982
[TBL] [Abstract][Full Text] [Related]
15. Beta-arrestin2 enhances beta2-adrenergic receptor-mediated nuclear translocation of ERK.
Kobayashi H; Narita Y; Nishida M; Kurose H
Cell Signal; 2005 Oct; 17(10):1248-53. PubMed ID: 16038799
[TBL] [Abstract][Full Text] [Related]
16. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.
Appleton KM; Lee MH; Alele C; Alele C; Luttrell DK; Peterson YK; Morinelli TA; Luttrell LM
Methods Enzymol; 2013; 522():229-62. PubMed ID: 23374189
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling.
Zhang X; Szeto C; Gao E; Tang M; Jin J; Fu Q; Makarewich C; Ai X; Li Y; Tang A; Wang J; Gao H; Wang F; Ge XJ; Kunapuli SP; Zhou L; Zeng C; Xiang KY; Chen X
Circ Res; 2013 Feb; 112(3):498-509. PubMed ID: 23104882
[TBL] [Abstract][Full Text] [Related]
18. beta 2-adrenergic receptor activates extracellular signal-regulated kinases (ERKs) via the small G protein rap1 and the serine/threonine kinase B-Raf.
Schmitt JM; Stork PJ
J Biol Chem; 2000 Aug; 275(33):25342-50. PubMed ID: 10840035
[TBL] [Abstract][Full Text] [Related]
19. Isoproterenol and cAMP block ERK phosphorylation and enhance [Ca2+]i increases and oxygen consumption by muscarinic receptor stimulation in rat parotid and submandibular acinar cells.
Soltoff SP; Hedden L
J Biol Chem; 2010 Apr; 285(18):13337-48. PubMed ID: 20207737
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction. Bringing channels closer to the action!
Laporte SA; Oakley RH; Caron MG
Science; 2001 Jul; 293(5527):62-3. PubMed ID: 11441172
[No Abstract] [Full Text] [Related]
[Next] [New Search]
